Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
Sonu Bhaskar(New South Wales Department of Health), Daniel Razansky(University of Zurich), Jesús M. de la Fuente(Universidad de Zaragoza), Vasilis Ntziachristos(Helmholtz Zentrum München), Furong Tian(Kunming University), Paul J. A. Borm(InfoConsult (Germany)), Valeria Grazú(Universidad de Zaragoza), Giovani Estrada(National College of Ireland), Tobias Stoeger(Helmholtz Zentrum München), Wolfgang G. Kreyling(Institute of Groundwater Ecology)
Cited by 491
Related Papers
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
|Particle and Fibre Toxicology|2005|2.1k
Shedding light onto live molecular targets
|Nature Medicine|2003|1.9k
Looking and listening to light: the evolution of whole-body photonic imaging
|Nature Biotechnology|2005|1.6k
The potential risks of nanomaterials: a review carried out for ECETOC.
|Particle and Fibre Toxicology|2006|1.3k